Silphium Asset Management LTD Amgen Inc Transaction History

Silphium Asset Management LTD

  • $280 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2025
SELL
$229.03 - $291.01 $281,477 - $357,651
-1,229 Closed
0 $0
Q2 2022

Jan 30, 2025
SELL
$230.71 - $256.74 $46,142 - $51,348
-200 Reduced 14.0%
1,229 $299 Million
Q1 2022

Jan 30, 2025
BUY
$219.27 - $242.57 $313,336 - $346,632
1,429 New
1,429 $346 Million

Others Institutions Holding AMGN

# of Institutions
3,083
Shares Held
401M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Silphium Asset Management LTD Portfolio

Follow Silphium Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Silphium Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email